P56LCK A LYMPHOCYTE-SPECIFIC PROTEIN-TYROSINE KINASE - ACTIVATION, REGULATION AND SIGNAL-TRANSDUCTION

被引:0
作者
FISCHER, S
MARIECARDINE, A
RAMOSMORALES, F
BOUGERET, C
SOULA, M
MARIDONNEAUPARINI, I
BENAROUS, R
机构
[1] INST COCHIN GENET MOLEC,INSERM,U332,F-75014 PARIS,FRANCE
[2] CNRS,UPR 8221,F-75014 PARIS,FRANCE
关键词
P56LCK; CD45; CSK; SH2; CD2;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p56lck, a src family protein tyrosine kinase interacts with several T cell receptors, like: CD4, CD8, CD2 and the beta-chain of the IL2, thereby receptors devoided of kinase activity may transduce signals via tyr phosphorylation. Tyr 192 and ser 194, located in the SH2 domain of p56lck is phosphorylated upon CD3 triggering, which can change interactions of tyr-P proteins with this SH2 domain. Upon activation through the CD2 or the CD45 receptors the kinase activity of p56lck is temporarely increased. By immunofluorescent and confocal microscopy we observed that a significant proportion of p56lck and CD2 receptors are localized in endosomal vesicles after stimulation. By Western blot we showed a parallel recruitment of the PTK p70-ZAP in this vesicles. The role of p56lck away from the plasma membrane localized in vesicles is under study.
引用
收藏
页码:605 / 609
页数:5
相关论文
共 10 条
  • [1] BOUGERET C, 1993, ONCOGENE, V8, P1241
  • [2] BOTH T-CELL RECEPTOR (TCR)-CD3 COMPLEX AND CD2 INCREASE THE TYROSINE KINASE-ACTIVITY OF P56(LCK) - CD2 CAN MEDIATE TCR-CD3-INDEPENDENT AND CD45-DEPENDENT ACTIVATION OF P56(LCK)
    DANIELIAN, S
    ALCOVER, A
    POLISSARD, L
    STEFANESCU, M
    ACUTO, O
    FISCHER, S
    FAGARD, R
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (11) : 2915 - 2921
  • [3] THE TYROSINE KINASE-ACTIVITY OF P56LCK IS INCREASED IN HUMAN T-CELLS ACTIVATED VIA CD2
    DANIELIAN, S
    FAGARD, R
    ALCOVER, A
    ACUTO, O
    FISCHER, S
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (08) : 1967 - 1970
  • [4] THE LYMPHOCYTE-SPECIFIC PROTEIN TYROSINE KINASE P56LCK IS HYPERPHOSPHORYLATED ON SERINE AND TYROSINE RESIDUES WITHIN MINUTES AFTER ACTIVATION VIA T-CELL RECEPTOR OR CD2
    DANIELIAN, S
    FAGARD, R
    ALCOVER, A
    ACUTO, O
    FISCHER, S
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (12) : 2183 - 2189
  • [5] MARIECARDINE A, 1992, J IMMUNOL, V148, P3879
  • [6] MARIECARDINE A, 1994, IN PRESS EUR J IMMUN
  • [7] MUSTELIN T, 1994, MOL BIOL INTELLIGENC
  • [8] RAMOSMORALES F, 1994, IN PRESS ONCOGENE
  • [9] SONGYANG Z, 1993, CELL, V72, P1
  • [10] SOULA M, 1993, J BIOL CHEM, V268, P27420